Company: MBIO
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007736
Chunk: 15

Company: MUSTANG BIO, INC.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 4
Chunk 15
---
 and may never achieve or maintain profitability. We do not have any products that are approved for commercial sale and therefore do not expect to generate any revenues from product sales in the foreseeable future, if ever.

We have a limited operating history. We have focused primarily on organizing, acquiring and developing and securing our proprietary technology and identifying and obtaining preclinical data for various product candidates, with the goal of supporting regulatory approval for these product candidates. We have incurred losses since our inception in March 2015. Our net losses were $0.2 million and $5.2 million for the three months ended March 31, 2025 and 2024, respectively, and we had an accumulated deficit of $396.9 million as of March 31, 2025. We expect to continue to incur significant operating losses for the foreseeable future. We also do not anticipate that we will achieve profitability for a period of time after generating material revenues, if ever. If we are unable to generate revenues, we will not become profitable and may be unable to continue operations without continued funding.